Mayank Srivastava

1.2k citations
8 papers · 999 indexed · h-index 7
Topics
Cell death mechanisms and regulation (5 papers)Estrogen and related hormone effects (2 papers)Ubiquitin and proteasome pathways (2 papers)

In The Last Decade

Mayank Srivastava

8 papers receiving 974 citations

Peers

Mayank Srivastava
Comparison fields: 5 of 87
  • Molecular Biology 432
  • Pharmacology 419
  • Genetics 264
  • Cancer Research 227
  • Pulmonary and Respiratory Medicine 170
Replace Peter Pyrko with:
Peter Pyrko United States
Wen-Chun Hung Taiwan
Gen Fujii Japan
Majken Westergaard Denmark
Saori Furuta United States
Keiko Ogino Japan
Yoon Kyung Jo South Korea
Hélène Gaillard Spain
Michele Houston United States
Stanley J. Wertheimer United States
Mayank Srivastava relative to Peter Pyrko United States Peter Pyrko's profile →
Citations per field
00.5×8.5×
Peter Pyrko · 1×
Citations per year

Countries citing papers authored by Mayank Srivastava

Since Specialization
Citations

This map shows the geographic impact of Mayank Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayank Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayank Srivastava more than expected).

Fields of papers citing papers by Mayank Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayank Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayank Srivastava. The network helps show where Mayank Srivastava may publish in the future.

Co-authorship network of co-authors of Mayank Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Mayank Srivastava. A scholar is included among the top collaborators of Mayank Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayank Srivastava. Mayank Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 3
2 40
3 67
4 114
5 75
6 180
7 82
8 438

About Mayank Srivastava

Mayank Srivastava is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 8 papers that have together received 999 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Estrogen and related hormone effects (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Pharmacology (419 citations), Cancer Research (227 citations) and Biochemistry (100 citations). Mayank Srivastava has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Hasan Mukhtar, Nihal Ahmad, Sanjay Gupta, David G. Bostwick, Andreas Bergmann, Hermann Steller, Eli Arama, Kazuko Sakamoto, Maya Bader and César S. Mendes. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026